Indolent B-Cell Non-Hodgkin Lymphoma
Also known as: Indolent B-cell NHL / Indolent B-cell non-Hodgkin Lymphoma (NHL) / Indolent B-cell Non-Hodgkin's Lymphoma / Indolent B cell non-hodgkin lymphoma / Indolent B-Cell Non-Hodgkin's Lymphomas
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00928 | Azacitidine | 1 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB01073 | Fludarabine | 1 | Recruiting | 1 |
DB00480 | Lenalidomide | 1 | Active Not Recruiting | 1 |
DB16582 | Lisocabtagene maraleucel | 1 | Recruiting | 1 |
DB08935 | Obinutuzumab | 1 | Active Not Recruiting | 1 |
DB00073 | Rituximab | 1 | Completed | 1 |
DB17429 | BI-1206 | 1 / 2 | Recruiting | 1 |
DB17573 | Evorpacept | 1 / 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
DB00073 | Rituximab | 1 / 2 | Recruiting | 2 |
DB06769 | Bendamustine | 2 | Completed | 1 |
DB15434 | Mosunetuzumab | 2 | Recruiting | 1 |
DB00075 | Muromonab | 2 | Recruiting | 1 |
DB08935 | Obinutuzumab | 2 | Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB12240 | Polatuzumab vedotin | 2 | Recruiting | 1 |
DB18245 | Zandelisib | 2 | Active Not Recruiting | 1 |
DB06769 | Bendamustine | 3 | Terminated | 1 |